Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chemelectiva is an Italian contract research and development organization (CRO/CDMO) specializing in the chemical development of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Based in Novara, the company provides a comprehensive suite of services including route scouting, process optimization, and the development of non-infringing processes for generic drugs. Their expertise extends to solid-state chemistry, offering polymorph screening, salt selection, and analytical method development. Chemelectiva supports pharmaceutical partners from early-stage laboratory research through to small-scale GMP manufacturing for clinical trials. By leveraging advanced organic synthesis and regulatory support, they assist clients in bringing complex small molecule therapeutics to market efficiently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chemelectiva.